Norges Bank Y M Abs Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$37.86 - $54.26 $851,850 - $1.22 Million	-22,500 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$35.13 - $43.62 $790,425 - $981,450	22,500 New	22,500 $864,000
Q4 2018 Feb 08, 2019	SELL	$15.41 - $28.92 $231,150 - $433,800	-15,000 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$24.0 - $26.97 $360,000 - $404,550	15,000 New	15,000 $398,000

14.4M

24K

Ticker YMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,719,500
Market Cap $376M
Description
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.